Department of Pathology, Yale School of Medicine, New Haven, Connecticut, USA.
Cytopathology. 2023 Nov;34(6):597-602. doi: 10.1111/cyt.13283. Epub 2023 Aug 3.
The cytomorphological features of parathyroid tissue (PTT) may overlap with those of thyroid lesions, thus posing a diagnostic challenge. In this retrospective study, we reviewed our institutional experience in using parathyroid hormone (PTH) immunocytochemistry (ICC) to substantiate the diagnosis of PTT on fine needle aspiration (FNA).
Our pathology database was searched for FNA cases in which PTH ICC was performed between 1 January 2015 and 31 March 2022. PTH ICC was performed on a ThinPrep slide in cases with a clinical suspicion of PTT or with cytomorphological features raising the possibility of PTT. Patients' clinicopathological characteristics, PTH ICC results, cytological diagnoses, and surgical follow-ups, if available, were reviewed and analysed.
The study cohort included 103 cases clinically designated as thyroid (n = 85, 82.5%), parathyroid (n = 11, 10.7%) and neck soft tissue (n = 7, 6.8%). PTH immunostaining was negative, positive, and indeterminate in 53 (51.5%), 27 (26.2%), and 23 (22.3%) cases, respectively. Surgical follow-up was available in 27 (26.2%) cases, including 17 thyroid lesions and 10 PTT cases. All positive PTH cases were confirmed to be PTT, while all but one of the negative PTH cases were non-PTT on follow-up. The calculated sensitivity, specificity, positive and negative predictive values were 85.7%, 100%, 100% and 93.3%, respectively.
Our study demonstrates that PTH ICC performed on additional ThinPrep slides is a valuable adjunct test in FNA samples with a differential diagnosis of PTT vs non-PTT. Low cellularity may be a limiting factor in the accurate assessment of PTH by ICC.
甲状旁腺组织(PTT)的细胞形态特征可能与甲状腺病变重叠,因此诊断具有挑战性。在这项回顾性研究中,我们回顾了我们机构使用甲状旁腺激素(PTH)免疫细胞化学(ICC)来证实细针抽吸(FNA)中 PTT 诊断的经验。
我们的病理数据库搜索了 2015 年 1 月 1 日至 2022 年 3 月 31 日期间进行 PTH ICC 的 FNA 病例。在临床怀疑 PTT 或细胞学特征提示 PTT 时,在 ThinPrep 载玻片上进行 PTH ICC。回顾和分析了患者的临床病理特征、PTH ICC 结果、细胞学诊断以及如果有手术随访。
研究队列包括 103 例临床指定为甲状腺(n=85,82.5%)、甲状旁腺(n=11,10.7%)和颈部软组织(n=7,6.8%)的病例。PTH 免疫染色分别在 53 例(51.5%)、27 例(26.2%)和 23 例(22.3%)病例中呈阴性、阳性和不确定。27 例(26.2%)病例可获得手术随访,包括 17 例甲状腺病变和 10 例 PTT 病例。所有阳性 PTH 病例均证实为 PTT,而所有阴性 PTH 病例除 1 例外均在随访中证实为非 PTT。计算的敏感性、特异性、阳性和阴性预测值分别为 85.7%、100%、100%和 93.3%。
我们的研究表明,在 PTT 与非 PTT 鉴别诊断的 FNA 样本中,在额外的 ThinPrep 载玻片上进行 PTH ICC 是一种有价值的辅助检测方法。低细胞密度可能是 ICC 准确评估 PTH 的限制因素。